Completed NA INTERVENTIONAL 2-arm NCT03528707

Effect of Probiotic Co-administration With Omega-3 Fatty Acids on NAFLD

Effect of Probiotic Co-administration With Omega-3 Fatty Acids on NAFLD: Randomized Clinical Studies

Sponsor: Bogomolets National Medical University

Conditions NAFLD Omega-3 Fatty Acids Probiotic Type2 Diabetes

Updated 5 times since 2018 Last updated: Dec 15, 2019 Started: Apr 14, 2015 Primary completion: Dec 22, 2015 Completion: Jan 28, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03528707, this NA trial focuses on NAFLD and Omega-3 Fatty Acids and remains completed. Sponsored by Bogomolets National Medical University, it has been updated 5 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jan 2020 — Jan 2021 [monthly]

Completed NA
Jun 2018 — Jan 2020 [monthly]

Completed NA

First recorded

Apr 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bogomolets National Medical University

Data source: Bogomolets National Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.